Find Spinosyn D manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

77RELATED EXCIPIENT COMPANIES

118EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Spinosad factor d, 131929-63-0, A 83543d, Chebi:9232, 78g4631rtt, (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
Molecular Formula
C42H67NO10
Molecular Weight
746.0  g/mol
InChI Key
RDECBWLKMPEKPM-PSCJHHPTSA-N
FDA UNII
78G4631RTT

Spinosyn D
spinosyn D is a natural product found in Gossypium with data available.
1 2D Structure

Spinosyn D

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,2S,5R,7S,9S,10S,14R,15S,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
2.1.2 InChI
InChI=1S/C42H67NO10/c1-11-26-13-12-14-35(53-37-16-15-34(43(6)7)24(4)49-37)23(3)38(45)33-20-31-29(32(33)21-36(44)51-26)17-22(2)28-18-27(19-30(28)31)52-42-41(48-10)40(47-9)39(46-8)25(5)50-42/h17,20,23-32,34-35,37,39-42H,11-16,18-19,21H2,1-10H3/t23-,24-,25+,26+,27-,28+,29-,30-,31-,32+,34+,35+,37+,39+,40-,41-,42+/m1/s1
2.1.3 InChI Key
RDECBWLKMPEKPM-PSCJHHPTSA-N
2.1.4 Canonical SMILES
CCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C(=CC3C2CC(=O)O1)C)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)N(C)C
2.1.5 Isomeric SMILES
CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C
2.2 Other Identifiers
2.2.1 UNII
78G4631RTT
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Spinosyn-d

2.3.2 Depositor-Supplied Synonyms

1. Spinosad Factor D

2. 131929-63-0

3. A 83543d

4. Chebi:9232

5. 78g4631rtt

6. (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione

7. (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-13-{[(2r,5s,6r)-5-(dimethylamino)-6-methyltetrahydro-2h-pyran-2-yl]oxy}-9-ethyl-4,14-dimethyl-7,15-dioxo-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-1h-as-indaceno[3,2-d]oxacyclododecin-2-yl 6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranoside

8. 1h-as-indaceno3,2-doxacyclododecin-7,15-dione, 2-(6-deoxy-2,3,4-tri-o-methyl-.alpha.-l-mannopyranosyl)oxy-13-(2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yloxy-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2

9. Spinosad Factor D [usan]

10. Unii-78g4631rtt

11. Spinosyn D [mi]

12. Schembl465825

13. Chembl503450

14. Dtxsid3037599

15. Zinc85537011

16. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimet

17. Xs175291

18. J-006090

19. Q27108325

20. (2r,3as,5ar,5bs,9s,13s,14r,16as,16br)-2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-4,14-dimethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione

21. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o- Methyl-a-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5- (dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl- 2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-

22. 1h-as-indaceno(3,2-d)oxacyclododecin-7,15-dione, 2-((6-deoxy-2,3,4-tri-o-methyl-alpha-l-mannopyranosyl)oxy)-13-(((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2s,3ar,5as,5bs,9s,13s,14r,16as,16bs)-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 746.0 g/mol
Molecular Formula C42H67NO10
XLogP34.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count11
Rotatable Bond Count9
Exact Mass745.47649733 g/mol
Monoisotopic Mass745.47649733 g/mol
Topological Polar Surface Area111 Ų
Heavy Atom Count53
Formal Charge0
Complexity1330
Isotope Atom Count0
Defined Atom Stereocenter Count17
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

ChemWerth Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Chemwerth Compnay Banner

02

Rochem International Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rochem

03

Symbiotec Pharmalab

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSymbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Symbiotec Pharmalab

04

BrightGene Bio-Medical Technology ...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

BrightGene Bio-Medical Technology ...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

05

Corteva Agriscience

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Corteva Agriscience

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF arrow-down Others AUDIT
blank

06

Quimica Sintetica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Quimica Sintetica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT arrow-down
blank

07

Chongqing DaXin Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

08

Qilu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Qilu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF arrow-down Others AUDIT arrow-down
blank

09

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

10

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

AOCS Annual Meeting
Not Confirmed

01

AOCS Annual Meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-11-15

Pay. Date : 2021-09-16

DMF Number : 36293

Submission : 2021-09-27

Status : Active

Type : II

blank

02

Arvo
Not Confirmed

03

Quimica Sintetica Sa

Spain

USDMF

arrow
Arvo
Not Confirmed

03

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2024-09-11

Pay. Date : 2024-08-15

DMF Number : 40075

Submission : 2024-07-30

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Blepharitis.


Lead Product(s): Spinosyn D,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 06, 2024

blank

01

Aperta Biosciences, LLC

Country
arrow
Arvo
Not Confirmed

Aperta Biosciences, LLC

Country
arrow
Arvo
Not Confirmed

Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Blepharitis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 06, 2024

blank

Details:

Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Scabies.


Lead Product(s): Spinosyn D,Inapplicable

Therapeutic Area: Dermatology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Concentrics Research | IQVIA | Medpace, Inc | Inotiv | BioAgilytix

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 05, 2022

blank

02

Arvo
Not Confirmed
Arvo
Not Confirmed

Lead Product(s) : Spinosyn D,Inapplicable

Therapeutic Area : Dermatology

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : Concentrics Research | IQVIA | Medpace, Inc | Inotiv | BioAgilytix

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Scabies.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 05, 2022

blank

Details:

Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.


Lead Product(s): Spinosyn D,Inapplicable

Therapeutic Area: Dermatology Brand Name: Natroba

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Concentrics Research

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 30, 2015

blank

03

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

Lead Product(s) : Spinosyn D,Inapplicable

Therapeutic Area : Dermatology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Concentrics Research

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.

Product Name : Natroba

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 30, 2015

blank

Details:

Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.


Lead Product(s): Spinosyn D,Inapplicable

Therapeutic Area: Dermatology Brand Name: Natroba

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Concentrics Research

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 30, 2015

blank

04

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

Lead Product(s) : Spinosyn D,Inapplicable

Therapeutic Area : Dermatology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Concentrics Research

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Natroba (Spinosad) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.

Product Name : Natroba

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 30, 2015

blank

Details:

Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Lice Infestations.


Lead Product(s): Spinosyn D,Inapplicable

Therapeutic Area: Dermatology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 08, 2012

blank

05

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

ParaPRO

U.S.A
arrow
Arvo
Not Confirmed

Details : Spinosad is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Lice Infestations.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 08, 2012

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Rheology Modifiers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Arvo
Not Confirmed

CIPHER

Canada
arrow
Arvo
Not Confirmed

SPINOSAD

US Patent Number : 9895388

Drug Substance Claim :

Drug Product Claim :

Application Number : 22408

Patent Use Code : U-3365

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-11-25

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 131929-63-0 / Spinosyn D API manufacturers, exporters & distributors?

Spinosyn D manufacturers, exporters & distributors 1

69

PharmaCompass offers a list of Spinosyn D API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Spinosyn D manufacturer or Spinosyn D supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Spinosyn D manufacturer or Spinosyn D supplier.

API | Excipient name

Spinosyn D

Synonyms

Spinosad factor d, 131929-63-0, A 83543d, Chebi:9232, 78g4631rtt, (1s,2s,5r,7s,9s,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione

Cas Number

131929-63-0

Unique Ingredient Identifier (UNII)

78G4631RTT

About Spinosyn D

spinosyn D is a natural product found in Gossypium with data available.

Spinosyn D Manufacturers

A Spinosyn D manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Spinosyn D, including repackagers and relabelers. The FDA regulates Spinosyn D manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Spinosyn D API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Spinosyn D manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Spinosyn D Suppliers

A Spinosyn D supplier is an individual or a company that provides Spinosyn D active pharmaceutical ingredient (API) or Spinosyn D finished formulations upon request. The Spinosyn D suppliers may include Spinosyn D API manufacturers, exporters, distributors and traders.

click here to find a list of Spinosyn D suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Spinosyn D USDMF

A Spinosyn D DMF (Drug Master File) is a document detailing the whole manufacturing process of Spinosyn D active pharmaceutical ingredient (API) in detail. Different forms of Spinosyn D DMFs exist exist since differing nations have different regulations, such as Spinosyn D USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Spinosyn D DMF submitted to regulatory agencies in the US is known as a USDMF. Spinosyn D USDMF includes data on Spinosyn D's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Spinosyn D USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Spinosyn D suppliers with USDMF on PharmaCompass.

Spinosyn D NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Spinosyn D as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Spinosyn D API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Spinosyn D as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Spinosyn D and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Spinosyn D NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Spinosyn D suppliers with NDC on PharmaCompass.

Spinosyn D GMP

Spinosyn D Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Spinosyn D GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Spinosyn D GMP manufacturer or Spinosyn D GMP API supplier for your needs.

Spinosyn D CoA

A Spinosyn D CoA (Certificate of Analysis) is a formal document that attests to Spinosyn D's compliance with Spinosyn D specifications and serves as a tool for batch-level quality control.

Spinosyn D CoA mostly includes findings from lab analyses of a specific batch. For each Spinosyn D CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Spinosyn D may be tested according to a variety of international standards, such as European Pharmacopoeia (Spinosyn D EP), Spinosyn D JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Spinosyn D USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty